A Study to Determine the Safety, Tolerability and Effect on Liver Histologic Parameters of ARO-AAT
Scottsdale/Phoenix, AZ
The purpose of this study is to evaluate the safety, tolerability and effect on liver histologic parameters with administration of the investigational product, ARO-AAT, in participants with alpha-1 antitrypsin deficiency (AATD). Participants will receive multiple subcutaneous doses of ARO-AAT.